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Abstract
Background: Parkinson’s disease (PD) is an adult-onset movement disorder of largely unknown etiology. We have
previously shown that loss-of-function mutations of the mitochondrial protein kinase PINK1 (PTEN induced putative kinase
1) cause the recessive PARK6 variant of PD.
Methodology/Principal Findings: Now we generated a PINK1 deficient mouse and observed several novel phenotypes: A
progressive reduction of weight and of locomotor activity selectively for spontaneous movements occurred at old age. As in
PD, abnormal dopamine levels in the aged nigrostriatal projection accompanied the reduced movements. Possibly in line
with the PARK6 syndrome but in contrast to sporadic PD, a reduced lifespan, dysfunction of brainstem and sympathetic
nerves, visible aggregates of a-synuclein within Lewy bodies or nigrostriatal neurodegeneration were not present in aged
PINK1-deficient mice. However, we demonstrate PINK1 mutant mice to exhibit a progressive reduction in mitochondrial
preprotein import correlating with defects of core mitochondrial functions like ATP-generation and respiration. In contrast
to the strong effect of PINK1 on mitochondrial dynamics in Drosophila melanogaster and in spite of reduced expression of
fission factor Mtp18, we show reduced fission and increased aggregation of mitochondria only under stress in PINK1-
deficient mouse neurons.
Conclusion: Thus, aging Pink1
2/2 mice show increasing mitochondrial dysfunction resulting in impaired neural activity
similar to PD, in absence of overt neuronal death.
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Introduction
Parkinson’s disease (PD) is diagnosed mostly in elderly people by
clinical criteria, based on a typical progressive reduction of their
spontaneous movement activity in spite of preserved strength and
coordination. The clinical deficits reflect progressive neurodegen-
eration, with initial unspecific symptoms due to pathology in the
peripheral autonomic nervous system and in brainstem structures
such as the dorsal motor vagal nucleus and the noradrenergic
locus coeruleus neurons, and with a later typical movement deficit
due to pathology of the dopaminergic neurons projecting from the
midbrain substantia nigra to the striatum. Upon autopsy, the
diagnostic hallmark of PD is the presence of cytosolic protein
aggregates containing a-synuclein within the affected neurons
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5777(Lewy bodies). Damage by oxidative stress and mitochondrial
dysfunction is documented for affected brain areas, but the
molecular events underlying the pathogenesis are unknown.
Several neurotoxins and disease genes may cause variants of PD
differing in age of onset, manifestations and prognosis, but a
common pathway has remained elusive and a routine laboratory
diagnosis cannot yet be provided to patients.
A clear genetic link between mitochondria and PD was defined
by our identification of loss-of-function mutations in the
mitochondrial protein PINK1 as the cause of autosomal recessive
early-onset PARK6-linked Parkinsonism, a variant of PD with
particularly early onset and mild progression that affects the
autonomic and cognitive nervous system less than sporadic PD
[1,2]. PINK1 is a ubiquitously expressed 581 amino-acid protein
with a serine-threonine kinase domain and a mitochondrial signal
peptide [3]. In skin fibroblasts of 3 PARK6 patients with
homozygosity for the G309D-PINK1 mutation, we could
demonstrate an impaired activity of the respiratory complex I,
an induction of antioxidant defence enzymes and enhanced lipid
peroxidation [4], as well as altered a-synuclein mRNA levels [5].
Recombinant PINK1 can protect from apoptosis, modulate the
mitochondrial membrane potential [1], localize to mitochondrial
cristae [6] and was reported to phosphorylate the mitochondrial
chaperone TRAP1 [7] and the mitochondrial protease HTRA2
[8]. In Drosophila melanogaster, PINK1 deficiency leads to fragment-
ed mitochondrial cristae, hypersensitivity to oxidative stress,
muscle and neuronal degeneration [9,10] and is rescued by
overexpression of parkin and fission factors DRP1 or FIS1,
suggesting a physiological role of PINK1 in the dynamics or
degradation of mitochondria [11,12,13]. Previous studies of Pink1
knock-out (KO) mouse brain reported (1) elevated susceptibility to
H2O2 or heat-shock with decreased activities of the oxidative-stress
vulnerable respiratory complexes as well as aconitase [14], (2)
increased calcium levels and vulnerability with subsequent excess
ROS production, decreased glucose availability and loss of
mitochondrial membrane potential to cause pathological opening
of the mitochondrial permeability transition pore [15], (3) reduced
synaptic dopamine release and plasticity in the striatum [16], (4)
sensitization to activation of group II metabotropic glutamate
receptors at corticostriatal synapses [17] and (5) reduced viability
of cortical neuron cultures [18]. It remained unclear, however,
whether essential mitochondrial functions such as preprotein
import and fission/fusion are maintained in the mice, whether the
mitochondrial and synaptic dysfunction progress with age to
impair movement and behaviour and whether a neurodegenera-
tive process with a-synuclein aggregation is initiated. Since
PARK6 is a rare PD variant and patient brain autopsies are still
unavailable, the pathological features of PARK6 tissue remain
undefined.
To further elucidate the physiological role of PINK1 in
mammalian tissue and to gain insight in the disease mechanisms
of PARK6, we generated a PINK1 deficient mouse and assessed
degrees of mitochondrial dysfunction at old age and the
consequences for growth, motor performance, neuronal activity
and aggregation/degeneration.
Results
Generation of PINK1 deficient mice
The pathogenic G309D-PINK1 mutation of our PARK6
patients was inserted into the orthologous mouse locus, using a
neomycin (Neo) selection marker, flanked by loxP sites, engineered
in intron V (Fig. 1A). The targeting vector was designed to allow a
substitution of the G309D mutation, with minimal disruption of
the Pink1 gene. Homologous recombination in embryonal stem
cells was demonstrated by Southern blotting with an outside probe
(Fig. 1B) and presence of the mutation in tail DNA by PCR
amplification and restriction (Fig 1C). However, Northern blots
with a probe covering Pink1 exons III to VI demonstrated no full-
length Pink1 expression in the mice carrying this allele (Fig. 1D),
suggesting interference with gene expression by the presence of
Neo. The expression levels of the mutant Pink1 mRNA were
reduced by a factor of 14 when analyzed by the Affymetrix
transcriptome microarray and by a factor of 35 in quantitative real
time RT-PCR (qPCR). To assess whether the intense smaller band
detected by Northern blot represents a Pink1 isoform, qPCR
analysis of Pink1 mRNA sequences on both sides of the Neo
insertion site were performed and showed a 97% reduction in
homozygous mutant brain tissue in both cases, indicating that the
smaller band in Northern is due to unspecific cross-hybridization
(Fig. 1E). Saturation reverse transcriptase (RT) PCR of each
splicing boundary in brain and liver mRNA specifically detected
normally spliced amplicons in wildtype (wt) and heterozygous (ht),
but in homozygous tissues (hm) a smear of abnormally large
amplification products was found for the exon 5–6 boundary
suggesting the presence of intron 5 including the Neo selection
marker (Fig. 1F). Additional saturation RT-PCR experiments
confirmed the presence of Pink1 intron 5 and Neo sequences in the
residual Pink1 mRNA and demonstrated the existence of smears of
abnormally sized amplification fragments in homozygous tissue
(Fig. 1G), suggesting that a Pink1 mRNA with excessive size is
unstable and degraded to about 3% residual expression levels.
Endogenous PINK1 protein cannot be detected reliably, probably
due to very low expression levels [19]. Attempts to concentrate
endogenous PINK1 protein through degradation inhibition and
immunoprecipitation were promising in HEK293 but inconclusive
in tissues, because the antibodies cross-reacted with more
abundant proteins. Thus, a demonstration of the PINK1 protein
deficiency was not possible. Since a loss-of-function of PINK1 is
the cause of PARK6, these mice with a 97% knock-down of Pink1
transcript and a loss-of-function mutation in the remaining mRNA
represent a useful disease model. Their quality is similar to the
previously reported Pink1 knock-out mice generated by germline
deletion of exons 4–7 resulting in an abnormally sized transcript
which is probably degraded since no expression was detectable in
Northern blots [16]. The other published Pink1 knock-out mouse
was generated by deletion from exon 2 to 5 and is predicted to
produce an abnormally sized and unstable Pink1 transcript, but no
Northern or qPCR data are available and its sole expression
characterization was through Western blotting in spite of the
known problems to detect the endogenous PINK1 protein in
tissues [18]. Although residual amounts of abnormally spliced
Pink1 transcript would exist in all these Pink1 mutant mouse lines
and it could be speculated that residual amounts of PINK1 protein
with abnormal 39 sequences are relevant, it is highly probable that
mouse phenotypes would result from the engineered deficiency
rather than from sequence abnormalities of residual PINK1.
Progressive reduction of weight and of spontaneous
locomotor activity
While all PD variants show the typical deficit of spontaneous
locomotor activity from deficient dopaminergic nigrostriatal
signaling, early disease stages of non-inherited PD and some
inherited PD variants are accompanied by unspecific non-motor
symptoms such as hyperhidrosis (excessive sweating) caused by
dysfunctional sympathetic nerves [20] as well as altered stress
responses due to brainstem noradrenergic neuron pathology [21].
Although there is an ongoing debate which assays are best to
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PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e5777Figure 1. Generation and characterization of the Pink1
2/2 mouse. (A) Schematic drawing of the targeting strategy. (B) Demonstration of the
allele representing the homologous recombination event at the Pink1 locus by Southern blotting of the outside probe in the embryonal stem cell
line, (C) Presence of mutation in homozygous (hom) and heterozygous (het) mouse tail DNA represented by a double band (134+154 basepairs)
instead of the wildtype (wt) single band (288 bp) after exon 4 amplification and AvaII restriction. (D) Absence of Pink1 transcript expression in three
tissues of homozygous mutant versus heterozygous and wildtype mice by Northern blotting, using b-actin as control for equal loading and the 18S
and 28S ribosomal bands as references for size. One additional cross-reacting band showed intensities not correlating with the mutant genotypes. No
residual Pink1 transcripts of different sizes were detectable, indicating instability and degradation of the mutant mRNA. (E) 97% reduction of Pink1
mRNA in homozygous KO mice (n=5) in independent TaqMan systems detecting sequences upstream and downstream from the Neo insertion site.
(F) Saturation RT-PCR amplification of Pink1 mRNA sequences containing each splice site, studying brain and liver mRNA from wildtype, heterozygous
(ht) and homozygous (hm) mice, demonstrating abnormalities in homozygous tissues with additional large bands for the exon 4–5 splicing boundary
and smears of abnormally large size for the exon 5–6 boundary. (G) Saturation RT-PCR with primers from Pink1 intron 5 and the Neo selection marker
demonstrating the pathological presence of intronic and Neo sequences in Pink1 mRNA from mutant (ht and hm) mouse samples.
doi:10.1371/journal.pone.0005777.g001
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functional consequences of PINK1 deficiency for both motor
and non-motor nervous system deficits as well as growth and
survival of the whole organism, using homozygous mutant and
wildtype cohorts in pure 129/SvEv background, both derived
from the founding heterozygous animals.
Already at 1 year of age, the body weight of Pink1
2/2 mice
showed a significant reduction in average weight of up to 19%
(Fig. 2A), a finding which may reflect impaired bioenergetics and
mitochondrial dysfunction. This weight reduction occurred
although the animals were unlimited in their movement range
and certainly able to reach the food, although formal assessment of
food intake and metabolism was not performed. A significant
reduction of locomotor activity was not demonstrable until the age
of 16 months, possibly because wildtype mice from the 129/SvEv
strain are known for low motor activity. Impairment of
spontaneous movement became significant for several parameters
in open field analysis (Fig. 2B–F) of 16 animals of the first
homozygous generation. The measures for total distance (TOT-
DIST), horizontal activity (HACTV), movement time (MOV-
TIME), stereotypy count (STRCNT) and center distance
(CTRDIST) were all decreased by about 30% (p,0.05), while
measures for strength (Fig. S1), coordination (Fig. S2) and anxiety
(Fig. S3) remained normal. The significant deficit in spontaneous
movement activity was independently reproduced in subsequent
progeny of the first cohort (8 animals per group at age 24 months,
40–55% reduction with p,0.05 for each of the above parameters).
Such selective movement impairment is usually caused by reduced
Figure 2. Progressive phenotype upon visual inspection of Pink1
2/2 mice. Knock-out (KO) versus wildtype (WT) mice showed (A) a
consistent and progressive reduction of body weight from middle age and (B–F) a reduction of spontaneous movement, significant for the open-field
parameters (B) total distance, (C) horizontal activity, (D) movement time, (E) stereotypy counts and (F) center distance at advanced age.
doi:10.1371/journal.pone.0005777.g002
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be difficult to prove by behaviour tests since pharmacological
substitution of dopamine by L-Dopa or apomorphine would lead
to hyperactivity both in mutant and wildtype mice.
The movement deficit was not severe enough to reduce the
lifespan of PINK1 deficient mice (Fig. S4). Non-motor nervous
dysfunction was not detectable: Increased sweating was not
observed in aged Pink1
2/2 mice even under pharmacological
provocation (Fig. S5). Assessment of startle reflexes to acoustic
stimuli, which represent brainstem functions modulated by the
noradrenergic locus coeruleus neurons, did not reveal any
impairment (Fig. S6). Thus, the early features of sympathetic
affection and brainstem locus coeruleus pathology typically
documented in early stage sporadic PD were not observed in
our Pink1
2/2 mice, suggesting that the effect of PINK1 deficiency
in mouse does not reach this stage or has different tissue specificity.
In contrast, the movement deficit with selectivity for spontaneous
locomotor activity mirrors the diagnostic features of PD.
Deficiency of striatal dopamine at advanced age, in spite
of absent neurodegeneration in the dopaminergic
projection from the substantia nigra to the striatum
To investigate striatal dopaminergic signalling as the likely cause
of a selective deficit in spontaneous movement activity, high
pressure liquid chromatography (HPLC) studies of striatal tissue
dopamine levels were performed in PINK1 deficient mice. At ages
9 and 22–24 months, a significant reduction of dopamine content
was observed (Fig. 3). These findings extend a previous report of
altered dopamine release and synaptic plasticity in striatal slice
cultures from 3 months old Pink1 knock-out mice [16]. To
determine whether the onset of neurodegeneration underlies this
dopamine deficit at advanced ages, we performed a systematic
histological evaluation of neuron populations through Nissl
staining, of myelinated fibre tracts through Klu ¨ver-Barrera
counterstaining, and of astrogliosis through GFAP immunohisto-
chemistry in sections from the lower brainstem to the frontal
cortex taken at regular intervals. In agreement with the behaviour
tests excluding ataxia, peripheral paralysis, autonomic and
acoustic dysfunction, no obvious structural pathology was found
in the cerebellum, the brainstem and the cerebrum at large. In
view of the preferential susceptibility of nerve cells and nerve
terminals of the dopaminergic pathway from the substantia nigra
(SN) to the striatum to the disease process of PD and to
mitochondrial complex I toxins such as MPTP and rotenone, we
focussed on a thorough quantification of this projection with
morphological and biochemical criteria. After specific detection of
these cells with tyrosine hydroxylase (TH) immunohistochemistry
in brain tissue at age 18 months, the neuronal cell bodies were
counted by unbiased stereology in 30 serial sections covering the
whole SN. No loss of dopaminergic neurons was apparent in the
PINK1 deficient tissue (Fig. 4A–C). Furthermore, no reduction in
the optical density of TH-positive nerve terminals in the striatum
could be documented (Fig. 4D–F). Thus, the earlier report of
unchanged number of TH-immunoreactivity in the nigrostriatal
pathway in Pink1 knock-out mice until age 9 months [16] is
confirmed and extended to the age of 18 months in our mice.
Thus, the data suggest that the reduced locomotor activity in aged
PINK1 deficient mice might be caused by impaired dopaminergic
neurotransmission, but is not due to neurodegeneration in the
nigrostriatal projection.
Absence of Lewy bodies from brainstem and substantia
nigra neurons, which are known for their high
vulnerability in PD
To assess whether the protein aggregation typically seen in
neurons affected by PD is a feature of aged Pink1
2/2 brain, the
subcellular localization and expression of a-synuclein was studied
by immunohistochemistry, immunoblots and qPCR. A light-
microscopical inspection of brain sections at regular intervals
throughout the brain stained with a-synuclein immunohistochem-
istry did not reveal any visible cytoplasmic aggregates. In
particular, the substantia nigra was free of aggregates. Only in
the lower brainstem, enhanced a-synuclein immunoreactivity
within neurons in somatodendritic distribution and throughout
the neuropil was observed in independent analyses of the dorsal
motor nucleus of the vagus (Fig. S7). Enhanced expression and
somatodendritic distribution of a-synuclein correlate with aggre-
gation in several mouse mutants [22]. Therefore, quantification of
the a-synuclein expression was performed with immunoblots and
qPCR. Both in midbrain and in brainstem a slight increase in a-
synuclein protein levels did not reach significance. However, a-
synuclein mRNA levels in both regions were significantly reduced
(Fig. S8). These findings might indicate impaired degradation and
reduced re-synthesis of a-synuclein and suggest an emerging
protein clearance pathology.
Mitochondrial dysfunction is progressive from early ages
In order to understand how PINK1 deficiency results in
reduced growth, spontaneous locomotion and striatal dopamine
levels, we studied mitochondrial function in detail. Recombinant
PINK1 was previously localized to mitochondrial cristae [6] or
outer membrane [19], impaired respiratory activity and oxidative
stress are detectable in patient tissues, and PINK1 deficiency
phenotypes in Drosophila melanogaster mutants are rescued by factors
affecting mitochondrial dynamics [11,12,13]. Since PINK1-
related mitochondrial dysfunction was previously documented
not only in tissues affected by Parkinsonian neurodegeneration,
but also in skeletal muscle [9,10] and skin fibroblasts [4], it
probably represents an early mutation consequence and cannot be
the sole cause for tissue-specific disease vulnerability; we therefore
extended our study to liver and dissociated cells from whole brain.
Mitochondrial functions are dependent on a biogenesis process
that delivers proteins by a specific protein import reaction,
comprising three separate biochemical processes (recognition,
translocation to mitochondrial subcompartments and processing).
In view of the report on PINK1 phosphorylating the mitochon-
drial chaperone TRAP1 [7] and the role of chaperones in
mitochondrial preprotein import, we assessed the residual
Figure 3. Aged Pink1
2/2 brain contains decreased dopamine
amount. HPLC analysis of Pink1
2/2 striatal homogenates detected a
significant reduction of dopamine (DA) at 9 and 22–24 months of age
(n=8 for each group).
doi:10.1371/journal.pone.0005777.g003
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PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5777translocation competence of PINK1 mutant mitochondria by in
vitro import reactions using mitochondria isolated from liver tissue
obtained from Pink1
2/2 mice at different ages. To quantify
import, the necessary high number and purity of mitochondria
could be obtained from the homogeneous and mitochondria-rich
liver tissue, but not from brain. Mitochondria were incubated with
different radiolabeled precursor proteins destined for the matrix
compartment and the inner membrane. The translocation of the
rat ornithine transcarbamylase (OTC) precursor protein to its
protease-protected localization in the mitochondrial matrix
showed significant age-related progressive defects. Already at an
age of 3 months, a small but significant reduction of the import
efficiency of OTC could be observed. This import defect became
more severe at an age of 6 months and was reduced by nearly 50%
by the age of 18 months in comparison to age-matched wildtype
mitochondria (Fig. 5A–C). A similar import defect was observed
with the precursor of the human matrix malate dehydrogenase
(MDH), but also with cytochrome c1, an inner membrane
respiratory chain component (Fig. 5D–E). In contrast, the import
of the inner membrane phosphate carrier protein (PiC), which
utilizes a different translocation pathway [23] showed only minor
reductions (Fig. 5F), correlating with only minor reductions of the
inner membrane potential (Dym) in liver mitochondria (data not
shown).
The primary function of mitochondria consists of providing
cellular ATP by the process of oxidative phosphorylation. ATP
levels under basal conditions were significantly reduced in
dissociated Pink1
2/2 mouse neurons (Fig. 6A), similar to what
wasseen previously inPink1
2/2 Drosophila melanogastermuscle [9,10].
The mitochondrial membrane potential (Dym) of dissociated
Pink1
2/2 neuron-glia cultures and of isolated Pink1
2/2 brain
mitochondria showed a significant and progressive reduction even
under basal conditions, without the stress conditions published for
transfected SH-SY5Y cells [1] (by 19.4% and 13.8%, respectively,
at 6 months and 18.6% and 16.0% at 12 months, Fig. 6B–C). As a
potential correlate of the Dym reduction at old age, we investigated
the respiratory complex activity of purified mitochondria from 18
months old brain tissue. Reduced activity was observed for the
respiration with glutamate+malate using respiratory complexes
I+III+IV, as previously reported [14], but also for TMPD+ascor-
bate using respiratory complex IV (Fig. 6D–E).
The results indicate that a novel and early deficit in liver
mitochondrial preprotein import and a progressive impairment of
brain mitochondrial bioenergetics are prominent phenomena in
Figure 4. Aged Pink1
2/2 brain does not display the typical signs of Parkinsonian neurodegeneration. (A–C) Stereological counts of
dopaminergic neurons in midbrain tissue: (A) Tyrosine hydroxylase (TH) immunostaining of wildtype (WT) and Pink1
2/2 (KO) substantia nigra (SN)
and ventral tegmental area (VTA) (scale bar, 200 mm). (B) Nonbiased stereological quantification of TH-immunopositive cells from WT (n=5) and KO
(n=6) SN. The mean neuron count differed only by 113 cells. (C) Average number of unbiased sampled TH-immunopositive SN neurons in 30 serial
midbrain sections, covering the caudo-rostral axis (bregma 23.8 to 23.2) in WT (n=4) and KO (n=6) mice. Note that there are no significant
differences between the two graphs. (D–F) Optical density of dopaminergic nerve terminals in dorsal and ventral striatum: (D) TH immunostaining of
striatal sections from WT and KO mice (scale bar, 500 mm). (E, F) Optical density quantification of TH immunostaining density of dorsal (DS) and
ventral striatum (VS) from WT (n=5) and KO (n=6) mice. There were no significant differences in dorsal (mean WT 71.0, SEM 5.6; KO 66.9, SEM 2.6)
and ventral striatum (WT 80.6, SEM 5.4; KO 75.7, SEM 2.5).
doi:10.1371/journal.pone.0005777.g004
Figure 5. Progressive deficit in mitochondrial preprotein import. The reduction of mitochondrial import of (OTC) precursor protein in
Pink1
2/2 mouse liver mitochondria (n=2–4 animals for each group and age) was increasingly impaired with advanced age (A–C). Import of the
matrix and inner membrane markers human malate dehydrogenase (MDH) (D) and cytochrome c1 (E) was reduced, while import of the inner
membrane phosphate carrier protein (PiC) as marker of an alternative translocation pathway (F) was not affected in old animals.
doi:10.1371/journal.pone.0005777.g005
Mitochondria in PINK1-KO Mice
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2/2 mice and may be important contributors to the weight
and activity phenotypes.
Impairment of mitochondrial fission under stress and
Mtp18 reduction in Pink1
2/2neurons
Since several investigators have reported PINK1 to act as
mitochondrial fission factor in Drosophila melanogaster [11,12,13], we
analyzed whether fission impairment accompanies the mitochondrial
dysfunction in PINK1 deficient mice, studying primary neuron
culture and aged brain tissue with fluorescent microscopy and
electron microscopy, respectively .U p o nf l u o r e s c e n ts t a i n i n gw i t h
Mitotracker, the mitochondria of postnatal cortical primary Pink1
2/2
neurons showed a normal distribution of morphotypes (Fig. 7A–E).
Under conditions of proteasomal stress, the amount of fragmented
mitochondria appeared reduced while the aggregated mitochondria
in a perinuclear localization were significantly increased (7F),
consistent with a role of PINK1 for stress-induced fission. Upon
electron microscopy of aged Pink1
2/2 brain, the loss of cristae
reported for Drosophila melanogaster could not be demonstrated
(Fig. 7G–H). To assess whether a possible alteration of mitochondrial
biogenesis or degradation results in altered levels of mitochondria, we
Figure 6. Progressive pathology of mitochondrial bioenergetic function in Pink1
2/2 brain. Reduced basal ATP level in Pink1
2/2
dissociated cells (A), reduction of basal mitochondrial membrane potential Dym in (B) dissociated cells and in (C) isolated mitochondria from Pink1
2/2
versus wildtype brain, as well as reduction of respiratory activities for complexes I+III+IV (Cx I) and IV (Cx IV) (D,E) substantiate a mitochondrial
dysfunction at old age.
doi:10.1371/journal.pone.0005777.g006
Mitochondria in PINK1-KO Mice
PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e5777quantified marker proteins of the mitochondrial inner and outer
membrane from aged Pink1
2/2 brain with immunoblots. No
significant differences were observed (Fig. 7I). Since the relative
normality of mitochondrial dynamics in mouse brain contrasts with a
strong phenotype in Drosophila melanogaster after PINK1 loss, we
speculated that compensatory mechanisms in mammalian tissues
exist. Assessing the expression levels of other factors known to
modulate mitochondrial dynamics, no compensatory changes were
found. However, the significantly reduced transcript level of the
recently described fission factor MTP18, consistent from 2 days to 18
months of age (Table 1), substantiated the subtle impairment of
mitochondrial fission. In spite of the Dym reduction in aged Pink1
2/2
brain, the ratio among the various processed isoforms of the fusion
factor OPA1 remained normal (Fig. S9). Thus, mitochondrial
morphology appears to be relatively balanced in PINK1 deficient
mammalian tissue, unless cell stress is present.
Figure 7. Early stress-induced deficit of mitochondrial fission in Pink1
2/2 neurons. Postnatal primary cortical neuron cultures stained with
Mitotracker were analyzed by quantification of mitochondrial morphotypes (A=fragmented, B=tubular, C=long tubular/network, D=aggregated)
under unstressed conditions (E) or after proteasomal stress with MG132 (F). Without stress, there were no differences in the mitochondrial
morphology between wildtype and Pink1
2/2 neuronal cells. Under stress, fewer fragmented mitochondria and significantly more aggregated
mitochondria were detected in Pink1
2/2 neurons, indicating a loss of stress-induced fragmentation in Pink1
2/2. Electron microscopy failed to
demonstrate a loss of cristae or other conspicuous structural pathology, as seen in two representative sections from of Pink1
2/2 brain at age 18
months (G, H). Immunoblots of marker proteins residing in inner (complex I–V) or outer mitochondrial membranes (porin) from 3 different mice of
age 21 months did not show a proliferation of mitochondrial mass or an altered inner versus outer membrane ratio (I).
doi:10.1371/journal.pone.0005777.g007
Mitochondria in PINK1-KO Mice
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In this study, we generated PINK1 deficient mice to elucidate
the physiological function of PINK1 and to model human
PARK6, a particularly interesting variant of PD in view of its
monogenic loss-of-function mechanism and its putative mitochon-
drial pathogenesis. Here, for the first time we report a phenotype
of motor impairment at old age with characteristics similar to PD,
together with evidence of dopaminergic synapse dysfunction and
prominent mitochondrial dysfunction, which is detectable early
under stress through impaired fission and appears also in tissues
unaffected by PD such as liver, but which worsens with increasing
age just like the motor deficit and includes a prominent deficit of
preprotein import. Related mechanisms of mitochondrial dys-
function are likely also important in the more frequent sporadic
form of PD in elderly people, since an increased frequency of
somatic mitochondrial DNA deletions was recently observed in
midbrain tissue of such patients, with consequent respiratory chain
deficiency and probably oxidative stress [24].
PINK1 deficiency and mitochondrial dysfunction
Mitochondria are important mediators of neural function and
synaptic plasticity [25]. Our observation that PINK1 deficiency in
mouse brain leads to a combined impairment of activity of
respiratory complex I+III+IV and II+III+IV, mitochondrial
membrane potential Dym and ATP generation at old age are
consistent with a defect in mitochondrial bioenergetic function.
They extend previous reports about reduced Dym and elevated
oxidative stress in human dopaminergic neuron cultures with Pink1
knock-down [18] and about reduced mitochondrial respiration
and increased sensitivity to oxidative stress in Pink1 knock-out mice
and Drosophila melanogaster [14,26]. In addition, our investigation of
liver tissue revealed a mitochondrial import defect, which
primarily affected preproteins targeted to the matrix compart-
ment, indicating that the reduction of translocation efficiency was
not solely caused by a reduced inner membrane potential. Due to
the basic relevance of preprotein import for mitochondrial
biogenesis, the observed defects could significantly contribute to
the respiration deficiencies in PINK1 mutant mitochondria.
Although the chain of events leading to this respiration deficit is
currently not understood, the findings constitute a robust assay for
the progressive pathology induced by PINK1 deficiency. While all
data agree that PINK1 exerts an important, but possibly
secondary effect on mitochondrial bioenergetics, the function of
PINK1 for mitochondrial dynamics, fragmentation and degrada-
tion appears less prominent in mouse tissue. In PINK1 deficient
Drosophila melanogaster, several independent groups reported clear-
cut pathology of mitochondrial cristae and elongation of
mitochondrial networks as evidence for a PINK1 role in fission
dynamics [11,12,13]. In contrast, the study of mammalian PINK1
deficient tissue produced controversial findings: human cells with
knocked-down or mutant Pink1 showed either a paradoxical
increase in fragmented mitochondria [27] or proliferation of
mitochondria with abnormal morphology [18]. PINK1 deficient
mice showed normal mitochondrial mass and structural integrity
with a marginal increase of mitochondrial size [14]. Our
observation of selective reduction of Mtp18 transcript in PINK1
deficient tissue at different ages represents evidence of a subtle
fission deficit and identifies a candidate molecule in the PINK1
pathway. MTP18 was recently described as a transcriptionally
regulated target of phosphatidylinositol 3-kinase signalling that is
localized within mitochondrial membranes and is thought to
provide the limiting step during the fission process of the inner
membrane, in parallel to the action of FIS1 at the outer
membrane [28,29]. While our data indicate mitochondria of
PINK1 deficient mice to have normal morphology and mass in
aged brain, they did show enhanced perinuclear aggregation after
proteasomal stress, suggesting that PINK1 plays a role in
mitochondrial fission and/or autophagic degradation (mitophagy).
In PINK1-deficient mouse brain tissue under physiological
conditions, this function can apparently be compensated by
downstream components of the same pathway, while very recent
data showed a stable Pink1 knock-down in human SH-SY5Y
neuroblastoma cell culture to induce mitochondrial fragmentation
and autophagy [30]. PINK1 has been shown to act upstream of
the ubiquitin ligase parkin [9,10], which is required for autophagic
clearance of damaged mitochondria [31]. PINK1 was found to
reside in the mitochondrial outer membrane with its kinase
domain facing the cytosol [19] and was claimed to phosphorylate
cytosolic parkin, mediating the translocation of parkin to
mitochondria [32]. Thus, PINK1 might be a sensor of
mitochondrial or cellular stress, and might trigger the initiation
of mitophagy through parkin activation [33]. In accordance with
this hypothesis, the loss of PINK1 would become noticeable under
stress through a failed activation of mitophagy, resulting in the
observed perinuclear accumulation of mitochondria. Alternative
evidence indicates that PINK1 deficiency results primarily in a
bioenergetic deficit and oxidative stress and that damaged
mitochondrial fragments are removed and degraded in a
compensatory effort [30]. While elucidation of the precise actions
of PINK1 has to await the identification of PINK1-phosphoryla-
tion substrates, in Pink1
2/2 brain the bioenergetic deficit is clearly
more prominent than mitochondrial dynamics failure. Our data
that PINK1 deficiency becomes more evident under cell stress
Table 1. Expression levels of mitochondrial fission and fusion factors in Pink1
2/2 tissue.
TaqmanH assay mitochondrial function gene symbol liver 2 days brain 2 days liver 18 months brain 18 months
Mm00612599_m1 fusion MfnI ns ns ns ns
Mm00500129_m1 fusion MfnII ns ns ns ns
Mm00453879_m1 fusion OpaI ns ns ns ns
Mm00481580_m1 fission FisI ns ns ns ns
Mm01342903_m1 fission DrpI ns ns ns ns
Mm00466042_m1 fission Mtp18 red. 25%; p=0.04 red. 10%; p=0.09 red. 30%; p=0.0002 ns
A selective reduction of the fission factor Mtp18 mRNA levels in qPCR analysis was consistently significant at ages 2 days and 18 months for the particularly
mitochondria-rich and homogeneous liver tissue, while the effect missed significance for the mixed tissue brain.
red.=reduced by factor; ns=non-significant.
doi:10.1371/journal.pone.0005777.t001
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striatal neurons in PINK1-linked Parkinsonism, since these
neurons are known for high levels of oxidative stress from
dopamine metabolism. Apparently, mitochondrial dysfunction is
present in all tissues with PINK1 deficiency, while additional stress
factors explain the tissue specific pattern of neurodegeneration.
PINK1 deficiency and presynaptic dysfunction
Function in dependence on ATP levels and on membrane
potential characterizes mitochondria as well as presynaptic
vesicles, where dopamine is imported and stored until exocytotic
release. Our findings of reduced dopamine levels in Pink1
2/2
striatum at ages between 9 and 24 months extend previous
observations, which had reported normal dopamine content but
altered release and pathological synaptic plasticity upon electro-
physiological analyses of corticostriatal long-term depression and
potentiation in Pink1
2/2 striatum at ages before 9 months [16].
Since we found no evidence for a loss of dopaminergic terminals in
the striatum, a functional rather than structural deficit of
presynaptic processes is likely. Whether this relates to our
observation of expression changes for the presynaptically localized
a-synuclein in Pink1
2/2 brain tissue remains unresolved at
present. Mitochondrial dysfunction together with a-synuclein
expression changes were also documented in fibroblasts from
patients with a PINK1 loss-of-function mutation [4,5,34]. The
gene dosage of a-synuclein is a known modulator of nerve terminal
density and function [35,36]. In view of the early impairment of
dopamine release and synaptic plasticity, as well as the subsequent
alteration of striatal dopamine levels and the a-synuclein
dysregulation before the advent of neurodegeneration in Pink1
2/
2 mice, we propose that nerve terminal dysfunction underlies the
selective deficit in spontaneous locomotor activity.
The PINK1 deficient mouse as a model of PD
neuropathology
The locomotor syndrome displayed by the aged Pink1
2/2
mouse is a robust finding, since it was observed in mice with pure
129/SvEv background, through comparison with littermates/
closely related control mice, and confirmed in a subsequent
progeny cohort. This phenotype is very reminiscent of PD: the
progressive reduction of spontaneous movements despite pre-
served strength and coordination, as well as its manifestation at
adult age. In addition, some of the pathophysiological features of
PD were also found in PINK1-deficient mice: (i) the reduced
dopamine content of the striatum; (ii) the altered expression of a-
synuclein mRNA; (iii) a mitochondrial dysfunction that is bound to
result in the enhanced oxidative stress susceptibility previously
published for Pink1
2/2 mice [14]. However, several non-motor
signs of early sporadic PD as well as features present in the final
stage autopsy tissue such as nigral cell loss and Lewy bodies were
not detectable in these mice even after 18 months. Thus, mouse
dopaminergic neurons seem to be less susceptible to cell death
induced by PINK1-deficiency, when compared with human
dopaminergic neurons where PINK1 deficiency was reported to
elicit age-related reduction of viability in a cell culture model [18].
Since PARK6 is a rare variant of PD and autopsy nervous tissue
from PARK6 patients has not yet become available, the degree of
nigral cell loss and Lewy pathology remains unclear for PARK6-
linked PD.
In conclusion, we demonstrate for the first time that PINK1
deficiency in mammalian tissue leads to progressive impairment of
preprotein import into mitochondria and altered fission-fusion
balance under stress, an early phenotype of mitochondrial
dysfunction which may well underlie the impaired bioenergetics
observed in aged brain tissue. Although neurodegeneration is not
detectable within the lifespan of mice and survival remains
unchanged, the alteration of dopamine, a-synuclein levels and the
novel observation of impaired spontaneous locomotion at old age
suggest an accompanying presynaptic pathology which might
model early stages of PD.
Methods
Generation of Pink1
2/2 mice
A mouse genomic bacterial artificial chromosome library
constructed from strain 129/SvEv was screened using a cDNA
Pink1 probe. A targeting vector was constructed with a 4.2 kb
NheI/NheI fragment containing exon II, III, IV and V as well as a
3.2 kb NheI/BstZ17I fragment. In exon IV, the mutation g/a in
position 8343 at position NT_039267 (resulting in the pathogenic
G309D mutation) was previously introduced with the Quick-
Change site directed mutagenesis kit (Stratagene) and primers
ctacccagaaggcctggaccacggtcgtacactg and cagtgtacgaccgtggtc-
caggccttctgggtag (Fig. 1A). Embryonic stem (ES) cell colonies that
were resistant both to aminoglycoside G418 and 29-fluoro-
29deoxy-1-b-D-arabinofuranosyl-5-iodouracil (FIAU) were
screened with Southern blotting (AccI digestion and outside
probe) to identify correctly targeted cell clones (Fig. 1B) and the
correctly targeted clones used for blastocyst injections. F1
heterozygous animals with a pure inbred 129/SvEv background
were used to derive homozygous mutant and wildtype mouse lines
maintained through breeding among homozygotes. Heterozygous
animals were not analyzed further, in view of cage space
limitations and in order to reduce genotyping efforts to PCR.
Animal husbandry guidelines from the German Animal Welfare
Act, the Council Directive of 24 November 1986 (86/609/EWG)
with Annex II and the ETS123 (European Convention for the
Protection of Vertebrate Animals) were followed, keeping the lines
at the FELASA-certified Central Animal Facility (ZFE) of
Frankfurt University Medical School. Genomic DNA was isolated
from tail biopsies and routine genotyping occurred with the
following three different PCR amplifications (for primer sequences
compare Table S1): (i) demonstration of the point mutation using
PCR primers exon 4 mouse F/exon 4 mouse R to generate a DNA
amplicon of 464 bp and a subsequent AvaII restriction digest to
fragments of 288 bp/176 bp in wildtype versus 176 bp/154 bp/
134 bp in the homozygotes, (ii) detection of the Neo selection
marker with PCR primers Pink1intron5F/NeoR, (iii) deletion
detection with PCR primers Pink1intron5F/Pink1intron5R. RNA
was isolated from brain, liver and skeletal muscle with Trizol
reagent (Invitrogen) to test expression. cDNA synthesis was carried
out with SuperScript III (Invitrogen), the PCR of individual Pink1
mRNA exon boundaries was performed with AmpliTaq (Ap-
pliedBiosystems) using the primers detailed in Table S1. The
quantitative real-time RT-PCR was done with TaqMan gene
expression assays Mm00550823_m1 and Mm00550827_m1.
Behaviour and motor function
All tests were performed in an initial cohort of 16 (7 females and
9 males) homozygous Pink1
2/2 and 16 wildtype (6 females and 10
males) mice at 4, 10 and 16 months of age. General health and
neurological performance were evaluated with the SHIRPA test
[37]. The weight as a measure of metabolism, nest-building as a
measure of normal development, and the production of urine/
faeces during 5 minutes open field/5 minutes Rota-Rod tests
together with center/margin time during open field test as
measures of anxiety were observed and recorded. To assay
strength and coordination, grip-strength, inverted-screen, pole-
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previous training as described previously [38]. The spontaneous
movement of mice in a 20620 cm arena was registered by infra-
red beams in a Digiscan monitor (AccuScan, Columbus, OH)
[38]. Open field spontaneous movement was reassessed in a
second cohort of homozygous progeny at the ages 9 and 24
months, the same animals which were later sacrificed for
dopamine neurochemistry. Hyperhidrosis assays were performed
as published [39,40]. Acoustic startle tests were carried out as
described previously [21].
Histological analysis of brain tissue
Two 16 month old brains from Pink1
2/2 and wildtype mice
were fixed with 4% paraformaldehyde, embedded in Paraplast-
plus and cut in 5 mm thick coronal consecutive sections from the
brainstem to the striatum. The first of every five sections was
subjected to Nissl staining of neurons and Klu ¨ver-Barrera
counterstaining of myelinated nerve fiber tracts.
Immunohistochemistry
The second of every five sections was immersed in 3% H2O2,
0.05 M Tris, 0.9% NaCl, pH 7.5 for 30 minutes, washed and
immersed for 60 minutes in 0.25% Triton 6100, 5% BSA and
0.1 M DL-lysine for a-synuclein immunohistochemistry. Sections
were incubated overnight in the first antibody (anti-a-synuclein
from Transduction labs at 1:200, anti-TH from Pel Freeze at
1:1000, GFAP from Sigma at 1:500) at room temperature. On the
next day after rinsing, sections were incubated for one hour at
room temperature with the appropriate secondary biotinylated
antibody. Following washes, sections were incubated for 1 hour
with the avidin-biotin-peroxidase complex (1:100, ABC-Elite,
Vector Laboratories). Following several washes, the sections were
reacted in a 3,3-diaminobenzidine tetrahydrochloride solution
(0.07% DAB and 0.002% H2O2). The sections were dehydrated
and mounted.
Stereological analysis and Optical density
Non-biased stereological analysis of TH-positive somata in
complete serial sections of the midbrain using the Stereoinvesti-
gator Software package (MFB Bioscience) and optical density
analysis of striatal TH immunoreactivity were performed as
described previously [41].
Dopamine levels in HPLC
The striatum was homogenized in 20–40 volumes of cold
150 mM potassium phosphate buffer, pH 6.8. Each homogenate
was aliquoted to analyze the protein concentration according to
Lowry and analyze the dopamine content in parallel, using high
performance liquid chromatography (HPLC) coupled to electro-
chemical detection, following a previously pulished method [42]:
One aliquot was diluted (K) with 0.4 N perchloric acid containing
0.4 mM sodium disulfite, 0.90 mM EDTA and the corresponding
internal standard (dihydroxybenzylamine for catecholamines).
Afterwards, samples were centrifuged for 3 min (15000 g) and
the supernatants directly injected into the HPLC system. The
HPLC system consisted of the following elements: The pump was
an isocratic Spectra-Physics 8810. The column was a RP-18
(Spherisorb ODS-2; 150 mm, 4.6 mm, 5 mm particle size; Waters,
Massachusetts, USA). The mobile phase, previously filtered and
degassed, consisted of 100 mM citric acid, 100 mM sodium
acetate, 1.2 mM heptane sulphonate, 1 mM EDTA and 7%
methanol (pH 3.9). The flow rate was 0.8 ml/min. The effluent
was monitored with a coulochemical detector (Coulochem II,
ESA) using a procedure of oxidation/reduction (conditioning cell:
+360 mV; analytical cell #1: +50 mV; analytical cell #2:
2340 mV), a procedure that reaches a sensitivity of 50 nA
(10 pg per sample). The signal was recorded on a Spectra-Physics
4290 integrator. The results were obtained from the peaks and
calculated by comparison with the area under the corresponding
internal standard peak. Values were expressed as ng/mg of
protein.
Immunoblots
Protein extraction and immunoblotting were performed as
described previously [4], with primary antibody titers as follows:
anti-a-synuclein (1:500, BD Transduction Laboratories), anti-b-
actin (1:10000, Sigma), anti-tyrosin-hydroxylase (1:1000, Pel
Freez). For densitometry, the Image Master Total Lab software
(Amersham Pharmacia) was used. As protein markers of inner and
outer mitochondrial membranes, MitoProfile Rodent Total
OXPHOS complexes (Mitosciences) and Porin (Calbiochem)
antibodies were used. Formation of OPA1 isoforms in total cell
extracts from heart, brain (frontal cortex), and liver tissues was
analyzed by immunoblotting using affinity-purified antibodies
raised against the C-terminus of OPA1 [43].
Transcript levels
18 months old mice brains were dissected to use one hemisphere
for RNA, the other hemisphere for protein extraction. Cerebel-
lum, brain stem, midbrain and cortex were extracted separately
with Trizol (Invitrogen) following manufacturer’s instructions. The
RNA from striatum was extracted with RNeasy Lipid tissue mini
kit from Qiagen. Total RNA was digested with DNAse
amplification grade (Invitrogen), one microgram was reverse
transcribed using pd(N)6 and NotI d(T)18 primers and the High
Capacity kit (Applied Biosystems), and the qPCR was carried out
in 20 ml on an ABI Prism 5700 sequence detection system. The
changes of transcripts (qPCR TaqmanH assays Mm00447331_m1
for Snca or a SYBRGreen assay with primers 59-TGGCAGT-
GAGGCTTATGAAA-39 and 59-ATGACTGGGCACATTG-
GAAC-39) were validated after independent cDNA synthesis with
SuperScript III Reverse Transcriptase in a qPCR with Ywhaz
(Mm01158417_g1) and Gapdh (Mm99999915_g1) as internal
control. Expression changes were analyzed both with the 2
2DDCt
method.
Mitochondrial membrane potential (Dym) and ATP level
Dissociated brain cells were prepared as described [44]. To
measure Dym, the cells were plated on a 24 well plate and
incubated for 15 min with 0.4 mM of the fluorescence dye
rhodamine 123 (R123). ATP levels in dissociated brain cells were
determined using the bioluminescent measurement of ATP as
published [45]. The preparation of isolated mitochondria was
conducted as published [46], measuring Dym with R123 at a final
concentration of 0.4 mM with the Victor multiplate reader (Perkin
Elmer Life Sciences) at 490 nm (excitation)/535 nm (emission).
The data (n=8) are expressed at fluorescence units per mg/ml
protein. The effects were robust across independent preparations,
irrespective of the percentage of glia admixture to neuronal cells in
culture.
Respirometry
The whole brains of twenty two mice aged to 21–23 months
were rapidly removed, washed and placed in ice-cold buffer
containing 225 mM mannitol, 75 mM sucrose, 5 mM HEPES,
BSA (1 mg/ml), 1 mM EGTA, pH 7.4. The tissue was then
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supplemented with nagarase (0.5 mg/ml) and then homogenized
with the use of motor-driven Teflon-glass Potter homogenizer.
After two time dilution, the homogenate was then centrifuged at
20006g for 9 min. The supernatant was decanted and centrifuged
at 120006g for 11 min. To permeabilize synaptosomes, the pellet
was suspended in isolation buffer supplemented with digitonin
(0.2 mg/ml) and homogenized manually. Finally the suspension
was centrifuged at 120006g for 11 min. The mitochondrial pellet
was resuspended in isolating medium at a protein concentration of
20–40 mg/ml. All procedures were carried out at 4uC. Mito-
chondrial oxygen consumption was measured at 30uC using an
Oroboros oxygraph (Anton Paar, Austria) in a medium containing
10 mM KH2PO4, 60 mM KCl, 60 mM Tris, 5 mM MgCl2, 110
mannitol and 0.5 mM EDTA-Na2, pH 7.4. 10 mM glutama-
te+5 mM malate were used as respiratory substrates for complexes
I+III+IV (Cx I) and 500 mM TMPD (N,N,N9,N9-tetramethyl-p-
phenylendiamine)+1 mM ascorbate as respiratory substrates for
complex IV (Cx IV). The concentration of mitochondria was
0.3 mg protein/ml.
Mitochondrial import
Isolation of mitochondria from mouse liver and import of
proteins was performed essentially as described [47]: In brief, the
mouse liver was homogenized in ice-cold solution A (0.22 M
mannitol, 0.07 M sucrose, 0.02 M HEPES, pH 7.6, 1 mM
EDTA, 0.1% BSA, 1 mM PMSF). Cell debris was removed by
centrifugation at 1,500 g for 5 min. Mitochondria were pelleted by
centrifugation at 10,000 g for 10 min and resuspended in solution
B (0.22 M mannitol, 0.07 M sucrose, 0.02 M HEPES, pH 7.6,
1 mM EDTA, 1 mM PMSF). Both centrifugation steps were
repeated three times. Radiolabelled pre-ornithine-transcarbamyl-
ase (pOTC) was generated by in vitro transcription and translation
in rabbit reticulocyte lysate and imported into isolated mitochon-
dria after dilution in import buffer (20 mM HEPES-KOH,
pH 7.6, 250 mM sucrose, 5 mM MgAc, 160 mM KAc, 5 mM
succinate, 5 mM malate, 1 mM DTT) to a final concentration of
125 to 250 mg/ml at 30uC in the presence of 3 mM ATP. In a
control sample, the membrane potential (Dym) was dissipated by
addition of 8 mM antimycin A, 0.5 mM valinomycin, and 2 mM
oligomycin. Non-imported preproteins were removed by trypsin
treatment. Samples were analyzed by SDS-PAGE and autoradi-
ography. Imported proteins were quantified using the Image-
Quant software (GE Healthcare). Isolation of mitochondria from
cultured fibroblasts was performed by homogenization of cells in
solution A and differential centrifugation as described [48].
Mitochondrial morphology
For fluorescent microscopic analysis, cortical neurons were
isolated from 4 day old wildtype or Pink1
2/2 mice as published
previously [49] and cultivated on cover slides. Cells were stained
with Mitotracker Red 14 d after isolation and fixed. Mitochondrial
morphology was divided into 4 morphotypes and quantified by
blinded investigators. To induce proteasomal stress, cells 13 d after
isolation were treated with 10 mM MG132 (Calbiochem) for 24 h
before fixation. n=3 for each condition, with at least 100 cells/
experiment. For electron microscopy, 4 brains from 22–24 months
old mice were fixed by transcardial perfusion with saline, followed
by perfusion and immersion using 2% paraformaldehyde (PFA),
cut into small blocks, which were postfixed with 4% PFA and
0.1% glutaraldehyde on ice for 2 h. After being washed twice in
PBS with 0.02% glycine, the small blocks were infused with 2.3 M
sucrose overnight, mounted on small metal pins, frozen and stored
in liquid nitrogen. Ultrathin sections were cut at 2110uC using a
diamond knife (Diatome) in an ultracryomicrotome (Leica),
collected using a 1:1 mixture of 1.8% and 2.3 M sucrose and
deposited on formvar- and carbon-coated grids. Sections were
contrasted with uranyl acetate methyl cellulose on ice for 10 min,
embedded in the same solution and examined with a Phillips
CM120 electron microscope.
Statistics
The statistical evaluation of data by unpaired two-tailed t-test or
survival plots and their graphical documentation for figures was
carried out with the GraphPad software. Significance was
indicated by asterisks (* for p,0.05; ** for p,0.01; *** for
p,0.001).
Supporting Information
Table S1 Primer sequence information.
Found at: doi:10.1371/journal.pone.0005777.s001 (0.03 MB
DOC)
Figure S1 Lack of peripheral paralysis. Normal motor perfor-
mance of Pink12/2 (n=16) mice at age 16 months in grip
strength tests indicated intact muscular and peripheral nervous
system.
Found at: doi:10.1371/journal.pone.0005777.s002 (2.55 MB TIF)
Figure S2 No deficit of coordination in Rota-Rod tests. The
ability to maintain equilibrium on a rotating rod was similar for
naı ¨ve Pink12/2 (n=16) and wildtype (n=16) mice at 16 months
of age.
Found at: doi:10.1371/journal.pone.0005777.s003 (1.70 MB TIF)
Figure S3 Normal measures of anxiety in Pink12/2 mice. The
quantification of margin time versus center time in open field tests,
which correlate to exploration versus anxiety, did not show a
significant difference in 16 months old animals (n=16 for each
group). Furthermore, the counting of fecal boli deposited showed
no abnormality.
Found at: doi:10.1371/journal.pone.0005777.s004 (1.17 MB TIF)
Figure S4 Normal lifespan of Pink12/2 mice. A survival curve
of 55 Pink12/2 versus 46 wildtype mice showed no significant
differences.
Found at: doi:10.1371/journal.pone.0005777.s005 (2.72 MB TIF)
Figure S5 Lack of autonomic dysfunction in hyperhidrosis
assays. Provocation of hyperhidrosis with pilocarpine showed
similar responses in two different assays for Pink12/2 (n=11)
and wildtype (n=11) mice at 18 months of age.
Found at: doi:10.1371/journal.pone.0005777.s006 (1.46 MB TIF)
Figure S6 Lack of brainstem pathology in acoustic startle tests.
The quantification of startle responses of 8–10 (n=8 for each
group) and 24 months old (n=8 for each group) Pink12/2 mice
(KO) to acoustic stimuli varying from 90 to 120 decibels (db) failed
to detect a significant difference from wildtype values (WT),
indicating normal function of noradrenergic neuron pathways in
the locus coeruleus.
Found at: doi:10.1371/journal.pone.0005777.s007 (1.88 MB TIF)
Figure S7 Lack of Lewy bodies in Pink12/2 brain. Immuno-
histochemical analyses did not detect the round or elongated
aggregates of a-synuclein within the neuronal cytoplasm, which
characterize Lewy pathology in PD affected cells. However,
enhanced a-synuclein immunoreactivity (brown color, with blue
hematoxylin counterstain) throughout the lower Pink12/2 (KO)
brainstem with somatodendritic distribution in the dorsal motor
vagal nucleus (nucl. X) (Cbll.=cerebellum, Area Post.=area
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magnification) was apparent in independent stains of various
Pink12/2 mice (B, D), but not wildtype mice (A, C).
Found at: doi:10.1371/journal.pone.0005777.s008 (2.01 MB TIF)
Figure S8 Reduced expression of a-synuclein mRNA in
Pink12/2 brain. Dissected brain areas from Pink12/2 (n=5)
and wildtype (n=5) 24 months old PINK1-deficient mice were
extracted for protein and mRNA. Normalized levels of alpha-
synuclein (SNCA) in brainstem and midbrain consistently showed
an increase for the protein, which missed significance, but a
significant decrease for the corresponding mRNA.
Found at: doi:10.1371/journal.pone.0005777.s009 (1.15 MB TIF)
Figure S9 Unchanged OPA1 isoforms in Pink12/2 tissue at
age 18 months. Total cell extracts of heart, brain (frontal cortex),
and liver tissues of wild type (WT) and Pink12/2 (KO) mice were
generated and equal amounts of total protein were analyzed by
SDS-PAGE and immunoblotting using antibodies raised against
the C-terminus of OPA1. Formation of OPA1 isoforms is not
affected by the presence of PINK1. OPA1 isoforms (L1, L2, S3,
S4, S5) and putative fragments (f, f9) are indicated.
Found at: doi:10.1371/journal.pone.0005777.s010 (1.90 MB TIF)
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